BioScrip and MDP-backed Option Care to merge
Home and alternate site infusion therapy providers BioScrip and Option Care have agreed to merge. No financial terms were disclosed. The deal is expected to close in the second half of this year. Jefferies LLC and Moelis & Company LLC are acting as joint financial advisers to BioScrip with Gibson, Dunn & Crutcher LLP providing legal advice. Goldman Sachs and BofA Merrill Lynch are serving as financial advisers to Option Care while Kirkland & Ellis LLP are providing legal advice. Option Care is owned by Madison Dearborn Partners, LLC and Walgreens Boots Alliance Inc.
15 March 2019•9 mins read
